Figure 2From: Emerging role of anti-tumor necrosis factor therapy in rheumatic diseasesHistopathologic psoriasis plaques. Epidermal and dermal characteristics of psoriasis plaques from a representative patient (a) before and (b) 10 weeks after infliximab treatment.Back to article page